Jeff Johnson
Stock Analyst at Baird
(4.56)
# 205
Out of 5,182 analysts
154
Total ratings
54.29%
Success rate
27.43%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Upgrades: Outperform | $78 → $100 | $73.85 | +35.41% | 11 | Feb 23, 2026 | |
| BBNX Beta Bionics | Maintains: Neutral | $28 → $14 | $9.73 | +43.88% | 3 | Feb 18, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Outperform | $18 → $30 | $18.28 | +64.11% | 17 | Dec 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $117 → $100 | $91.40 | +9.41% | 15 | Dec 16, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $85 → $98 | $69.66 | +40.68% | 19 | Dec 5, 2025 | |
| ALC Alcon | Maintains: Outperform | $95 → $98 | $74.67 | +31.24% | 11 | Nov 13, 2025 | |
| DXCM DexCom | Maintains: Outperform | $112 → $90 | $63.11 | +42.61% | 15 | Sep 26, 2025 | |
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $25.29 | -9.05% | 10 | May 27, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $332.07 | +21.96% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $166.87 | +65.40% | 18 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $202.46 | +17.55% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $22.52 | +210.83% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $13.65 | +346.89% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $11.52 | +481.60% | 6 | Feb 18, 2022 |
Henry Schein
Feb 23, 2026
Upgrades: Outperform
Price Target: $78 → $100
Current: $73.85
Upside: +35.41%
Beta Bionics
Feb 18, 2026
Maintains: Neutral
Price Target: $28 → $14
Current: $9.73
Upside: +43.88%
Tandem Diabetes Care
Dec 16, 2025
Upgrades: Outperform
Price Target: $18 → $30
Current: $18.28
Upside: +64.11%
Zimmer Biomet Holdings
Dec 16, 2025
Downgrades: Neutral
Price Target: $117 → $100
Current: $91.40
Upside: +9.41%
The Cooper Companies
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $98
Current: $69.66
Upside: +40.68%
Alcon
Nov 13, 2025
Maintains: Outperform
Price Target: $95 → $98
Current: $74.67
Upside: +31.24%
DexCom
Sep 26, 2025
Maintains: Outperform
Price Target: $112 → $90
Current: $63.11
Upside: +42.61%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $25.29
Upside: -9.05%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $332.07
Upside: +21.96%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $166.87
Upside: +65.40%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $202.46
Upside: +17.55%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $22.52
Upside: +210.83%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $13.65
Upside: +346.89%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $11.52
Upside: +481.60%